| Term 
 | Definition 
 
        | 15-45 years of age (child bearing age) normal, healthy females
 lack of structural or functional abnormalities
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | congenital abnormality distortion of urinary tract:
 obstruction - benign prostatic hypertrophy, stones or tumors, anticholinergic drugs
 nerulogic defect (prevents patient from completely emptying their bladder):  diabetes, stroke, spinal cord injury
 can affect both genders
 |  | 
        |  | 
        
        | Term 
 
        | Lower UTI = cystitis (bladder infection), urethritis (urethra), prostatitis (prostate), epididymitis (epididymis) dysuria
 urgency
 frequency
 suprapubic heaviness
 nocturia
 hematuria
 discolored or cloudy urine
 |  | Definition 
 
        | clinical presentation of lower UTI |  | 
        |  | 
        
        | Term 
 
        | upper UTI = pyelonephritis (kidney) flank pain
 back pain
 malaise
 fever
 N/V
 |  | Definition 
 
        | clinical presentation of upper UTI |  | 
        |  | 
        
        | Term 
 
        | altered mental status change in eating habits
 GI symptoms
 |  | Definition 
 
        | clinical presentation of UTIs in elderly |  | 
        |  | 
        
        | Term 
 
        | commonly will not have lower UTI symptoms fever and flank pain
 |  | Definition 
 
        | clinical presentation of UTIs from indwelling catheters or a neurologic disorder |  | 
        |  | 
        
        | Term 
 
        | routes of infection: ascending - urethra to bladder to kidneys
 hematogenous (descending) - uncommon
 lymphatic
 
 UTIs more common in females than males b/c of anatomic differences in location and length of urethra
 
 host defenses:
 urine - inhibition and killing of microorganisms (low pH)
 bladder - prevent bacterial adherence, colonization, and infection
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | (PEKS) Escherichia coli
 Staphylococcus saprophyticus
 Proteus
 Klebsiella
 |  | Definition 
 
        | common pathogens of Acute Uncomplicated Cystitis |  | 
        |  | 
        
        | Term 
 
        | (EC GUNS) Escherichia coli
 Staphylococcus spp.
 Chlamydia trachomatis
 Neisseria gonorrhoeae
 Gardenella vaginalis
 Ureaplasma urealyticum
 |  | Definition 
 
        | common pathogens of Symptomatic Abacteriuria |  | 
        |  | 
        
        | Term 
 
        | (PEEKS) Escherichia coli
 Staphylococcus saprophyticus
 Proteus
 Klebsiella
 Enterococcus faecalis
 |  | Definition 
 
        | common pathogens of Asymptomatic Bacteriuria |  | 
        |  | 
        
        | Term 
 
        | (PEKEP) Escherichia coli
 Enterococcus faecalis
 Pseudomonas aeruginosa
 Proteus
 Klebsiella
 |  | Definition 
 
        | common pathogens of Acute Pyelonephritis |  | 
        |  | 
        
        | Term 
 
        | Pseudomonas aeruginosa Enterococci
 |  | Definition 
 
        | common pathogens of Nosocomial UTIs |  | 
        |  | 
        
        | Term 
 
        | methods of urine collection: midstream catch - preferred method for routine collection
 catheterization - introduction of bacteria
 suprapubic bladder aspiration - bypasses contaminating organisms; newborns, paraplegics, seriously ill patients
 
 urine collection should meet specific criteria for significant bacteriuria
 
 culture and sensitivities:
 mid stream clean catch
 pour plate technique - most accureate, $$ and time consuming
 streak plate technique - most common, less costly
 
 screening urine for bacteria:
 DIPSTICKS - rapid screening
 leukocyte esterase (LE) - found in PMNs, indicates presence of WBCs
 nitrites - bacteria convert nitrates in the urine to nitrites; false negatives with Gram + or P. aeruginosa
 proteinuria - found in presence of infection
 pyuria - bacterial infection, presence of leukocytes
 hematuria - non-specific
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Treatment: TMP/SMX:  3 days
 OR
 Levofloxacin or Ciprofloxacin:  3 days
 OR
 Nitrofurantoin:  7 days
 OR
 Beta-lactam:  3 days
 
 Monitoring:  urine cultures not routinely recommended, but is recommended if:  symptoms persist during abx therapy or recur soon after therapy OR diagnosis is unclear based on medical history and physical exam
 |  | Definition 
 
        | treatment, duration, and monitoring of Acute Uncomplicated Cystitis |  | 
        |  | 
        
        | Term 
 
        | Treatment: TMP/SMX:  single dose
 OR
 TMP/SMX:  3 days
 If STD suspected take one of the following in combination with TMP/SMX:
 Azithromycin:  single dose
 OR
 Doxycyclin:  7 days
 
 Monitoring:  if symptoms do not response or recur:  obtain culture, consider treatment of concomitant STDs (Chlamydia trachomatis, Neisseria gonorrhoeae)
 |  | Definition 
 
        | treatment, duration, and monitoring of Symptomatic Abacteriuria |  | 
        |  | 
        
        | Term 
 
        | common in elderly, female, and *pregnant* patient specific:  treat pediatrics and pregnant women, don't treat non-pregnant adult females
 |  | Definition 
 
        | treatment of Asymptomatic Bacteriuria |  | 
        |  | 
        
        | Term 
 
        | Mild to moderate treatment: TMP/SMX:  14 days (preferred)
 OR
 Levofloxacin:  14 days
 
 Severe treatment:
 IV fluoroquinolones
 OR
 Aminoglycoside +/- ampicillin
 OR
 Aminoglycoside +/- extended spectrum cephalosporin
 
 Monitoring:
 effective therapy should stabilize patient in 12-24 hours
 reduction in urine bacteria in 48 hours
 once patient is afebrile D/C IV therapy
 follow up urine culture 2 weeks after completion of therapy
 |  | Definition 
 
        | treatment, duration, and monitoring of Acute Pyelonephritis |  | 
        |  | 
        
        | Term 
 
        | < 3 per year treat as separate infections > 3 per year treat conventionally then prophylaxis for 6 months:
 TMP/SMX:  daily for 6 months
 OR
 Trimethoprim:  daily for 6 months
 OR
 Nitrofurantoin:  daily for 6 months
 |  | Definition 
 
        | treatment and prophylaxis for recurrent UTIs |  | 
        |  | 
        
        | Term 
 
        | Antipseudomonal agent (Ceftazidime, Piperacillin/Tazobactam, Aztreonam, Meropenem, Imipenem) PLUS
 Aminoglycoside
 |  | Definition 
 
        | treatment of nosocomial UTI:  hospitalized w/in last 6 months, urinary catheter, nursing home resident |  | 
        |  | 
        
        | Term 
 
        | prolonged treatment = 10-14 days follow up with culture and sensitivities at 4-6 weeks after completion of treatment
 |  | Definition 
 
        | treatment of UTI in males |  | 
        |  | 
        
        | Term 
 
        | Amoxicillin/Clavulanate:  7 days OR
 Cephalexin:  7 days
 OR
 Nitrofurantoin:  7 days
 |  | Definition 
 
        | treatment of UTI in pregnancy:  urinary stasis, reduced defenses, increased nutrients encourages bacterial growth |  | 
        |  | 
        
        | Term 
 
        | signs and symptoms:  sudden fever, chills, myalgia, localized pain, urinary symptoms physical exam:  swollen, tender, or indurated gland
 labs:  bacteriuria, bacteria in prostatic secretions
 |  | Definition 
 
        | clinical presentation of acute prostatitis |  | 
        |  | 
        
        | Term 
 
        | signs and symptoms:  difficulty urinating, low back pain, perineal pressure physical exam:  indurated gland, enlarged gland
 labs:  bacteriuria, bacteria in prostatic secretions
 |  | Definition 
 
        | clinical presentation of chronic prostatitis |  | 
        |  | 
        
        | Term 
 
        | gram negative organisms: E. coli (most common), other enterics from the GI tract (Proteus, Klebsiella)
 
 infrequently gram positive organisms
 |  | Definition 
 
        | organisms most likely to infect the prostate gland |  | 
        |  | 
        
        | Term 
 
        | TMP/SMX:  4-6 weeks OR
 Levofloxacin or Ciprofloxacin:  4-6 weeks
 |  | Definition 
 
        | treatment and duration of acute prostatitis |  | 
        |  | 
        
        | Term 
 
        | TMP/SMX:  6-12 weeks OR
 Ciprofloxacin:  6-12 weeks
 OR
 Nitrofurantoin:  6-12 weeks
 |  | Definition 
 
        | treatment and duration of chronic prostatitis |  | 
        |  |